The global generics market is fast growing, driven by demand for cost-effective medicines and new availability of high value products. By now there are 17 generic companies with revenues in excess of US$1 billion, while there were only 12 in 2008/09.
The reports, books, and subscriptions listed under Research and Markets’ Generic Drugs category cover every aspect of this industry, such as market trends, forecasts, drivers and restraints, etc. They will allow you to identify business
opportunities and assess the strategies of the major players. You can also investigate the latest international and national patent opportunities across a vast number of INNs (international non-proprietary names), taking into account key concerns such as expiry dates, national regulations, etc.
Key players featured in our publications includes Teva Pharmaceutical, Mylan, Sandoz, Watson Pharmaceuticals, Greenstone, Par Pharma, Hospira, Apotex, Mallinckrodt, Dr. Reddy's, and more.